戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cetonitrile (where L = 1,4,7-trimethyl-1,4,7-triazacyclononane).
2 (mu-O)6]Br(3.5)(OH)0.5.6H2O (6, tacn = 1,4,7-triazacyclononane).
3 ymethyl-piperidine), was conjugated to 1,4,7-triazacyclononane, 1-glutaric acid-4,7 acetic acid (NODA
4 n fibrin-binding peptide conjugated to 1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid (NODAG
5             We also replaced DOTA with 1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid (NODAG
6 led PSMA-targeting radiotracer, (61)Cu-1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid (NODAG
7 a-OPS202 ((68)Ga-NODAGA-JR11; NODAGA = 1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid and JR
8 a-OPS202 ((68)Ga-NODAGA-JR11; NODAGA = 1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid and JR
9 ric acid-4,7 acetic acid (NODAGA), and 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and radiol
10 ASRI was synthesized with the chelator 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) at the ami
11 pe 2 (HER2) Nanobody with (68)Ga via a 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) derivative
12 importantly, nonspecific attachment of 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) on nanogra
13  N'', N'''-tetraacetic acid (DOTA) and 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA), and the c
14 studies show that the novel [(64)Cu]Cu-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-TP is stab
15 ing agent S-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-NOTA) a
16 ugated to 2-S-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-NOTA) a
17 ugated to 2-S-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-NOTA) a
18 ugated to 2-S-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-NOTA) a
19 ated with S-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-NOTA) t
20 ugated to 2-S-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid and labeled with
21 MWEWECFERK-CONH2) was constructed with 1,4,7-triazacyclononane-1,4,7-triacetic acid at the N terminus
22 ugated to S-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid for (64)Cu radiol
23 pain digestion and conjugated to NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid) for (64)Cu label
24 (3) NOTA-Bn ( S-2-(4-thioureidobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid) has a significan
25 )Cu-NOTA-8-Aoc-BBN(7-14)NH(2)] (NOTA = 1,4,7-triazacyclononane-1,4,7-triacetic acid, 8-Aoc = 8-aminoo
26 cid; or with (67)Ga using the chelator 1,4,7-triazacyclononane-1,4,7-triacetic acid.
27 made from S-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid; HSG is histamine
28                                 (68)Ga-1,4,7-triazacyclononane-1,4,7-triacetic-acid-ubiquicidin29-41
29                             (NODAGA is 1,4,7-triazacyclononane-1,4-bis[acetic acid]-7-[2-glutaric aci
30  were functionalized with the chelator 1,4,7-triazacyclononane-1-glutaric acid-4,7-diacetic acid (NOD
31 tacn=1-(2'-pyridylmethyl)-4,7-dimethyl-1,4,7-triazacyclononane) (2) generated during catalytic water
32 8)F-AlF-RESCA-IL2) and (68)Ga-gallium-(1,4,7-triazacyclononane-4,7-diacetic acid-1-glutaric acid)-IL2
33 rolysis reactions catalyzed by Co(III) 1,5,9-triazacyclononane and Eu(III) were 1.0006 and 1.0016, re
34 ranium tris-aryloxide complexes supported by triazacyclononane are described.
35 (MePy2tacn)](PF6)2 (1), containing a neutral triazacyclononane-based pentadentate ligand, and a termi
36 ePy2tacn = N-methyl-N,N-bis(2-picolyl)-1,4,7-triazacyclononane) by reaction of [Fe(II)(MePy2tacn)(sol
37 8)](2+) (Me(3)tacn = N,N',N"-trimethyl-1,4,7-triazacyclononane) cluster affords K[(Me(3)tacn)(6)MnMo(
38 derivatives of para-substituted aryl-alkynyl triazacyclononane complexes are described.
39 2)tacn = methyl- N', N"-bis(2-picolyl)-1,4,7-triazacyclononane), [Fe(V)(N){PhB( t-BuIm)(3)}](+) (4, P
40 ted by the ligand N,N',N"-triisopropyl-1,4,7-triazacyclononane ((i)Pr(3)tacn) that can undergo rapid
41 ive cleavage of DNA, (1,4,7-trimethyl-1, 4,7-triazacyclononane)iron(III) chloride was recently introd
42  results suggest that (1,4,7-trimethyl-1,4,7-triazacyclononane)iron(III) chloride will be a useful re
43 CN)(3)] (Me(3)tacn = N,N',N"-trimethyl-1,4,7-triazacyclononane) is accomplished with the addition of
44 nd, either 1,4,7-tris(carbamoylmethyl)-1,4,7-triazacyclononane (L1) or 1,4,7-tris[(5-amino-6-methyl-2
45  including 1,4,7-tris(carbamoylmethyl)-1,4,7-triazacyclononane (L1), 1,4,8,11-tetrakis(carbamoylmethy
46 is[(5-amino-6-methyl-2-pyridyl)methyl]-1,4,7-triazacyclononane (L2).
47  [M(tacn)(2)](3+/2+) complexes (tacn = 1,4,7-triazacyclononane; M = Cr, Mn, Fe, Co, Ni) was examined
48 s of a cobalt(II) porphyrin with a copper(I) triazacyclononane macrocycle fastened on the distal face
49 lex bearing terminal N,N',N"-trimethyl-1,4,7-triazacyclononane (Me(3)TACN) ligands and its reaction w
50  the tridentate ligand 1,4,7-trimethyl-1,4,7-triazacyclononane (Me3tacn) and the cyclic alkyl/aryl C-
51                 Aluminum (18)F-labeled 1,4,7-triazacyclononane-N,N',N"-triacetic acid conjugated fola
52                                  Novel 1,4,7-triazacyclononane-N,N',N' '-triacetic acid (NOTA) based
53 lbumin in vivo, we synthesized a NOTA (1,4,7-triazacyclononane-N,N',N''-triacetic acid)-conjugated tr
54 acn = 1-(2-pyridylmethyl)-4,7-dimethyl-1,4,7-triazacyclononane, OTf = trifluoromethanesulfonate anion
55 acn)](2+) (Me(3)tacn = 1,4,7-trimethyl-1,4,7-triazacyclononane) produces trigonal tricopper complexes
56 )(2)(OH)(2){O(2)P(Me)OAr}](3+); tacn = 1,4,7-triazacyclononane; substituent = m-F, p-NO(2) (1a); p-NO
57 N4) = 1-[2-pyridylmethyl]-4,7-dimethyl-1,4,7-triazacyclononane) such as a highly reactive cobalt(I) (
58  and carboxylate (DOTMA(4-)) arms] and 1,4,7-triazacyclononane (TACN) [i.e., with phosphonate (NOTP(6
59  complexes frequently show substituted 1,4,7-triazacyclononane (tacn) as the ligand.
60 um group and a Cu(II) ion ligated to a 1,4,7-triazacyclononane (TACN) ligand at the 1,3-distal positi
61                          We disclose a 1,4,7-triazacyclononane (TACN) ligand featuring an appended bo
62 ntate bis(phenoxide) ligand based on a 1,4,7-triazacyclononane (TACN) scaffold for the formation of w
63 7,10-tetraazacyclododecane (cyclen) or 1,4,7-triazacyclononane (tacn) unit(s) tethered via a short am
64           Cyclic triureas derived from 1,4,7-triazacyclononane (TACN) were synthesized; X-ray crystal
65  complexes of N-mustard derivatives of 1,4,7-triazacyclononane (tacn), 1,4,7,10-tetraazacyclododecane
66 in the presence of FeCl(2) or FeCl(3), 1,4,7-triazacyclononane (TACN), and pyridine in methanol is th
67  In a multiple-bond metathesis reaction, the triazacyclononane (tacn)-anchored methyl- and neopentyl
68 ,7-tris[(6-carboxypyridin-2-yl)methyl]-1,4,7-triazacyclononane), taking into account the effect of su
69 Manganese complexes of 1,4,7-trimethyl-1,4,7-triazacyclononane (tmtacn) are highly active and selecti
70 lick" reaction with copper-64 ((64)Cu)-1,4,7-triazacyclononane triacetic acid (NOTA) azadibenzocycloo
71 9-41 (TGRAKRRMQYNRR) was conjugated to 1,4,7-triazacyclononane-triacetic acid (NOTA), radiolabeled wi
72 5beta1 integrin-binding pseudopeptide on the triazacyclononane-triphosphinate (TRAP) chelator, follow
73   On the basis of the (68)Ga chelators TRAP (triazacyclononane-triphosphinate) and NODAGA, we synthes
74 : On the basis of the (68)Ga chelators TRAP (triazacyclononane-triphosphinate) and NODAGA, we synthes
75                              The macrocyclic triazacyclononane tris-aryloxide derivative occupies six
76 )Cu(3)(mu(3)-S(2))]X(2) (L = 1,4,7-trimethyl-triazacyclononane, X = O(3)SCF(3)(-) or SbF(6)(-)).